Recent findings showed that PKM2 de-adhesion of SIRT5 significantly reduced the levels of IL-1β produced by macrophages, which in turn ameliorated dextran sulfate sodium salt (DSS)-induced colitis in mice [130], suggesting that PKM2 could be an effective target for the treatment of IBD. This evidence concerns the gene PKM and inflammatory bowel disease.